Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision
Previous revision
ad [2023/07/03 15:34] – created - external edit 127.0.0.1ad [2025/05/25 04:35] (current) – [Alzheimer's Disease and Mild Cognitive Impairment] sflitman
Line 4: Line 4:
  
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
-| Mild to Moderate AD |  Novel Regenerative Injection   II  |  Yes  |  33%  |  26 weeks  |  26 weeks  |  +MCI and Mild AD |  Anti-Tau Vaccine   II  |  Yes  |  33%  |  4 years |  Anticipated 
-| MCI and Mild AD |  Filamin A Normalizer  |  III  |  Yes  |  50%  | 1 year  |  Anticipated  |+
  
 Also see [[imaging|Imaging]]. Also see [[imaging|Imaging]].
  
 +<html><!--</html>
 +| MCI and Mild AD |  Anti-Tau Intravenous Antibody  |  II  |  Yes  |  50%  |  12 weeks  |  No  | 
 +<html>--></html>
  
 ====== Response Form ====== ====== Response Form ======
Print/export
QR Code
QR Code ad (generated for current page)